Gotowa bibliografia na temat „Serine protease inhibitor”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Serine protease inhibitor”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Serine protease inhibitor"
Mitchell, Angela M., i R. Jude Samulski. "Mechanistic Insights into the Enhancement of Adeno-Associated Virus Transduction by Proteasome Inhibitors". Journal of Virology 87, nr 23 (11.09.2013): 13035–41. http://dx.doi.org/10.1128/jvi.01826-13.
Pełny tekst źródłaAvanzo, Petra, Jerica Sabotič, Sabina Anžlovar, Tatjana Popovič, Adrijana Leonardi, Roger H. Pain, Janko Kos i Jože Brzin. "Trypsin-specific inhibitors from the basidiomycete Clitocybe nebularis with regulatory and defensive functions". Microbiology 155, nr 12 (1.12.2009): 3971–81. http://dx.doi.org/10.1099/mic.0.032805-0.
Pełny tekst źródłaHudig, D., N. J. Allison, T. M. Pickett, U. Winkler, C. M. Kam i J. C. Powers. "The function of lymphocyte proteases. Inhibition and restoration of granule-mediated lysis with isocoumarin serine protease inhibitors." Journal of Immunology 147, nr 4 (15.08.1991): 1360–68. http://dx.doi.org/10.4049/jimmunol.147.4.1360.
Pełny tekst źródłaAzouz, Nurit P., Andrea Klingler, Victoria Callahan, Ivan Akhrymuk, Katarina Elez, Lluís Raich, Brandon Henry i in. "Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2–Priming Protease TMPRSS2". Pathogens and Immunity 6, nr 1 (26.04.2021): 55–74. http://dx.doi.org/10.20411/pai.v6i1.408.
Pełny tekst źródłaWoodard, S. L., D. S. Jackson, A. S. Abuelyaman, J. C. Powers, U. Winkler i D. Hudig. "Chymase-directed serine protease inhibitor that reacts with a single 30-kDa granzyme and blocks NK-mediated cytotoxicity." Journal of Immunology 153, nr 11 (1.12.1994): 5016–25. http://dx.doi.org/10.4049/jimmunol.153.11.5016.
Pełny tekst źródłaBrüning, Mareke, Martina Lummer, Caterina Bentele, Marcel M. W. Smolenaars, Kees W. Rodenburg i Hermann Ragg. "The Spn4 gene from Drosophila melanogaster is a multipurpose defence tool directed against proteases from three different peptidase families". Biochemical Journal 401, nr 1 (11.12.2006): 325–31. http://dx.doi.org/10.1042/bj20060648.
Pełny tekst źródłaHong, Tran Thi, Ton That Huu Dat, Nguyen Phuong Hoa, Tran Thi Kim Dung, Vu Thi Thu Huyen, Le Minh Bui, Nguyen Thi Kim Cuc i Pham Viet Cuong. "Expression and characterization of a new serine protease inhibitory protein in Escherichia coli". Biomedical Research and Therapy 7, nr 2 (29.02.2020): 3633–44. http://dx.doi.org/10.15419/bmrat.v7i2.590.
Pełny tekst źródłaCornwall, Gail A., Angus Cameron, Iris Lindberg, Daniel M. Hardy, Nathaly Cormier i Nelson Hsia. "The Cystatin-Related Epididymal Spermatogenic Protein Inhibits the Serine Protease Prohormone Convertase 2". Endocrinology 144, nr 3 (1.03.2003): 901–8. http://dx.doi.org/10.1210/en.2002-220997.
Pełny tekst źródłaYoo Im, Sonia, Camila Ramalho Bonturi, Adriana Miti Nakahata, Clóvis Ryuichi Nakaie, Arnildo Pott, Vali Joana Pott i Maria Luiza Vilela Oliva. "Differences in the Inhibitory Specificity Distinguish the Efficacy of Plant Protease Inhibitors on Mouse Fibrosarcoma". Plants 10, nr 3 (23.03.2021): 602. http://dx.doi.org/10.3390/plants10030602.
Pełny tekst źródłaÓ Cuív, Páraic, Rajesh Gupta, Hareshwar P. Goswami i Mark Morrison. "Extending the Cellulosome Paradigm: the Modular Clostridium thermocellum Cellulosomal Serpin PinA Is a Broad-Spectrum Inhibitor of Subtilisin-Like Proteases". Applied and Environmental Microbiology 79, nr 19 (19.07.2013): 6173–75. http://dx.doi.org/10.1128/aem.01912-13.
Pełny tekst źródłaRozprawy doktorskie na temat "Serine protease inhibitor"
Gariani, Talal. "Design of serine protease inhibitor peptides". Thesis, Imperial College London, 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.267244.
Pełny tekst źródłaCombe, Caroline Jane. "Hepatic receptor(s) for serine protease-inhibitor complexes". Thesis, University of Aberdeen, 1995. http://digitool.abdn.ac.uk/R?func=search-advanced-go&find_code1=WSN&request1=AAIU549619.
Pełny tekst źródłaSwedberg, Joakim Erik. "Rational design of serine protease inhibitors". Thesis, Queensland University of Technology, 2011. https://eprints.qut.edu.au/48131/1/Joakim_Swedberg_Thesis.pdf.
Pełny tekst źródłaWångsell, Fredrik. "Design and Synthesis of Serine and Aspartic Protease Inhibitors". Licentiate thesis, Linköping University, Linköping University, Organic Chemistry, 2006. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-7372.
Pełny tekst źródłaThis thesis describes the design and synthesis of compounds that are
intended to inhibit serine and aspartic proteases. The first part of the text deals with preparation of inhibitors of the hepatitis C virus (HCV) NS3 serine protease. Hepatitis C is predominantly a chronic disease that afflicts about 170 million people worldwide. The NS3 protease, encoded by HCV, is essential for replication of the virus and has become one of the main targets when developing drugs to fight HCV. The inhibitors discussed here constitute surrogates for the widely used N-acyl-hydroxyproline isostere designated 4-hydroxy-cyclopentene. The stereochemistry of the 4-hydroxy-cyclopentene scaffold was determined by nuclear overhauser effect spectroscopy (NOESY) and the regiochemistry by heteronuclear multiple bond correlation (HMBC). The scaffold was decorated with different substituents to obtain both linear and macrocyclic HCV NS3 protease inhibitors that display low nanomolar activity. The second part of the thesis describes the design and synthesis of potential aspartic protease inhibitors. The hydroxyethylene motif was used as a noncleavable transition state isostere. The synthetic route yielded a pivotal intermediate with excellent stereochemical control, which was corroborated by NOESY experiments. This intermediate can be diversified with different substituents to furnish novel aspartic protease inhibitors.
Report code: LIU-TEK-LIC-2006:45
Poliakov, Anton. "Peptide-Based Inhibitors of Hepatitis C Virus NS3 Serine Protease: Kinetic Aspects and Inhibitor Design". Doctoral thesis, Uppsala universitet, Institutionen för naturvetenskaplig biokemi, 2004. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4127.
Pełny tekst źródłaReinhard, Eva. "Cell and tissue localization of glia derived nexin, a serine protease inhibitor /". [S.l.] : [s.n.], 1989. http://e-collection.ethbib.ethz.ch/show?type=diss&nr=9040.
Pełny tekst źródłaEriksson, Röhnisch Kajsa. "Purification and Technical Application of a Serine Protease Inhibitor from Solanum tuberosum". Thesis, Uppsala universitet, Institutionen för biologisk grundutbildning, 2016. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-275284.
Pełny tekst źródłaelMasry, Nadia Farida. "Folding studies on mutants of Chymotrypsin Inhibitor 2". Thesis, University of Cambridge, 1993. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.309338.
Pełny tekst źródłaForney, John Russell. "Interaction of the Human Serine Protease Inhibitor Alpha-1-antitrypsin with Cryptosporidium parvum". DigitalCommons@USU, 1997. https://digitalcommons.usu.edu/etd/3961.
Pełny tekst źródłaFerreira, Graziele Cristina. "Purificação e caracterização de um inibidor de elastase de neutrófilos do feijão-caupi (Vigna unguiculata L Walp)". reponame:Repositório Institucional da UFABC, 2017.
Znajdź pełny tekst źródłaDissertação (mestrado) - Universidade Federal do ABC, Programa de Pós-Graduação em Biossistemas, 2017.
O Feijão Caupi (Vigna unguiculata (L.) Walp) é uma leguminosa com importante representatividade econômica e nutricional, especialmente no Brasil. Inibidores de serino proteases, como a tripsina, já foram descritos na espécie, assim como em outras plantas. No entanto, nesta espécie, ainda não foram identificados inibidores que apresentem atividade sobre a elastase de neutrófilos humana (HNE), protease envolvida em muitos processos patológicos, como na instalação e progressão da doença pulmonar obstrutiva crônica (DPOC). Nesse estudo, purificamos um inibidor a partir do extrato protéico de Vigna unguiculata que apresenta atividade sobre HNE. Inicialmente, foi realizado o processo de extração alcalina de proteínas, seguido de três passos cromatográficos distintos, utilizando as colunas Hitrap-Q (Troca-iônica), Source15RPC (Fase-Reversa) e ACE18 (Fase-Reversa). Essas etapas foram acompanhadas por testes de atividade inibitória, utilizando os substratos fluorogênicos Meo-Suc-Ala-Ala-Pro-Val-MCA (Elastase) e Z-Phe-Arg-MCA (Tripsina), além de ensaios da quantificação de concentração total de proteínas. Para determinar a massa do inibidor, foram utilizadas as técnicas de espectrometria de massa por MALDI-TOF e SDS-PAGE, o inibidor apresenta massa molecular de 10,99 KDa. O Ki para HNE foi determinado no valor de 9 pM. O inibidor não apresentou atividade inibitória sobre tripsina e trombina, porém foi observada atividade sobre subtilisina e quimotripsina. Estes dados indicam que o inibidor purificado trata-se de uma molécula ainda não caracterizada, devido às suas atividades inibitórias o nomeamos de Vigna unguiculata Elastase Inhibitor (VuEI).
The cowpea (Vigna unguiculata (L.) Walp) is a legume of important economic and nutritional representativeness, especially in Brazil. Serine protease inhibitors, such as trypsin, have been described in many species, as well as in other plants. In this specie an inhibitor with activity on human neutrophil elastase (HNE) has not yet been identified. This protease is involved in many pathological processes, such as the onset and progression of chronic obstructive pulmonary disease (COPD). We purified and characterized an inhibitor from the protein extract of Vigna unguiculata presenting activity towards HNE. Firstly, we performed the alkaline extraction procedure for proteins followed by three different chromatographic steps using Hitrap Q (ion exchange), Source15RPC (Reversed-Phase) and ACE18 (Reversed Phase) columns. These steps were followed by the inhibitory activity tests using fluorogenic substrates, MeO-Suc-Ala-Ala-Pro-Val-MCA (elastase) and Z-Phe-Arg-MCA (trypsin), and quantitation assays of protein concentration. To determinate the size of the molecule, we used MALDI-TOF mass spectrometry and SDS-PAGE. The molecular mass of the inhibitor was 10,99 kDa. The dissociation constant (Ki) toward HNE was 9 pM. HNE inhibitor showed no inhibitory activities toward trypsin and thrombin. However, the inhibitor presented activity toward subtilisin and chymotrypsin. These datas indicate that this molecule is a novel inhibitor to HNE and we named it Vigna unguiculata Elastase Inhibitor (VuEI).
Książki na temat "Serine protease inhibitor"
Festoff, Barry W., i Daniel Hantaï, red. Serine Proteases and Their Serpin Inhibitors in the Nervous System. Boston, MA: Springer New York, 1990. http://dx.doi.org/10.1007/978-1-4684-8357-4.
Pełny tekst źródłaCarthy, Barry Mc. Ovalbumin, gene Y and serpin inhibitory function. Dublin: University College Dublin, 1998.
Znajdź pełny tekst źródłaWest, A. Investigations by mass spectrometry of the interactions of novel serine protease inhibitors with Herpes Simplex Virus type 2 and Human Cytomegalovirus proteases. [s.l.]: typescript, 1999.
Znajdź pełny tekst źródłaBarnes, Ruth C. Identification and characterisation of a novel human serpin gene: Leupin. Dublin: University College Dublin, 1998.
Znajdź pełny tekst źródłaLai, Weidong George. Probing the stereospecificites of serine proteases using chiral aromatic aldehyde inhibitors and exploring the specificities of subtilisin lentus and its serine mutant. Ottawa: National Library of Canada, 1996.
Znajdź pełny tekst źródłaGeorgiev, Bojidor. Serpins and protein kinase inhibitors: Novel functions, structural features and molecular mechanisms. New York: Nova Science Publishers, 2010.
Znajdź pełny tekst źródłaNATO Advanced Research Workshop on Regulation of Extravascular Fibrinolysis in Nervous System Development and Disease (1989 Maratea, Italy). Serine proteases and their serpin inhibitors in the nervous system: Regulation in development and in degenerative and malignant disease. Redaktorzy Festoff Barry W, Hantaï Daniel i North Atlantic Treaty Organization. Scientific Affairs Division. New York: Plenum Press, 1990.
Znajdź pełny tekst źródłaVacca, Joseph P., Gerd Folkers, Raimund Mannhold i Hugo Kubinyi. Proteases as Drug Targets: Serine Proteases. Wiley & Sons, Incorporated, John, 2010.
Znajdź pełny tekst źródłaFestoff, Barry W. Serine Proteases and Their Serpin Inhibitors in the Nervous System. Springer, 1990.
Znajdź pełny tekst źródłaPoduch, Ewa. Kinetic studies of novel reversible and mechanism-based inhibitors of orotidine monophosphate decarboxylase and serine proteases. 2006.
Znajdź pełny tekst źródłaCzęści książek na temat "Serine protease inhibitor"
Gubernator, K., H. J. Ammann, C. Broger, D. Bur, D. M. Doran, P. R. Gerber, K. Müller i Th M. Schaumann. "Molecular modelling contributions to serine protease and serine esterase inhibitor design". W Trends in QSAR and Molecular Modelling 92, 52–58. Dordrecht: Springer Netherlands, 1993. http://dx.doi.org/10.1007/978-94-011-1472-1_7.
Pełny tekst źródłaFurukawa, Kenei, Tadashi Uwagawa i Katsuhiko Yanaga. "Anti-Tumor Effect of Synthetic Serine Protease Inhibitor". W Antitumor Potential and other Emerging Medicinal Properties of Natural Compounds, 205–12. Dordrecht: Springer Netherlands, 2013. http://dx.doi.org/10.1007/978-94-007-6214-5_13.
Pełny tekst źródłaSalek Maghsoudi, Armin, Shokoufeh Hassani, Kayvan Mirnia i Mohammad Abdollahi. "Serpin A12 (Vaspin) as a Serine Protease Inhibitor". W Biomarkers in Diabetes, 153–69. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-08014-2_7.
Pełny tekst źródłaSalek Maghsoudi, Armin, Shokoufeh Hassani, Kayvan Mirnia i Mohammad Abdollahi. "Serpin A12 (Vaspin) as a Serine Protease Inhibitor". W Biomarkers in Diabetes, 1–17. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-81303-1_7-1.
Pełny tekst źródłaFlecker, Peter. "Analysis of Structure-Activity Relationships of the Bowman-Birk Inhibitor of Serine Proteinases". W Protease Inhibitors as Cancer Chemopreventive Agents, 161–76. Boston, MA: Springer US, 1993. http://dx.doi.org/10.1007/978-1-4615-2882-1_9.
Pełny tekst źródłaNakamura, Takehiro, Yasuhiro Kuroda, Naohisa Hosomi, Naohiko Okabe, Nobuyuki Kawai, Takashi Tamiya, Guohua Xi, Richard F. Keep i Toshifumi Itano. "Serine Protease Inhibitor Attenuates Intracerebral Hemorrhage-Induced Brain Injury and Edema Formation in Rat". W Brain Edema XIV, 307–10. Vienna: Springer Vienna, 2009. http://dx.doi.org/10.1007/978-3-211-98811-4_57.
Pełny tekst źródłaTanzi, Rudolph E. "A Serine Protease Inhibitor Domain Encoded Within the Alzheimer Disease-Associated Amyloid ß-Protein Precursor Gene". W Serine Proteases and Their Serpin Inhibitors in the Nervous System, 313–19. Boston, MA: Springer New York, 1990. http://dx.doi.org/10.1007/978-1-4684-8357-4_28.
Pełny tekst źródłaSimon, Sanford R. "Oxidants, Metalloproteases and Serine Proteases in Inflammation". W Proteases, Protease Inhibitors and Protease-Derived Peptides, 27–37. Basel: Birkhäuser Basel, 1993. http://dx.doi.org/10.1007/978-3-0348-7397-0_3.
Pełny tekst źródłaSeto, Shinji, Masazumi Akahoshi, Shigeru Kusano, Shin-ichi Kitamura i Kunitake Hashiba. "Central Effect of Aprotinin, a Serine Protease Inhibitor, on Blood Pressure in Spontaneously Hypertensive and Wistar-Kyoto Rats". W Advances in Experimental Medicine and Biology, 49–54. Boston, MA: Springer US, 1989. http://dx.doi.org/10.1007/978-1-4615-9546-5_8.
Pełny tekst źródłaUrano, Tetsumei, Kiyohito Serizawa, Kenji Sakakibara, Leif Strandberg, Tor Ny, Yumiko Takada i Akikazu Takada. "The Cleavage of a Serine Protease Inhibitor at the Reactive Center by Its Target Protease: Analysis of the Substrate-Like Form of a Serpin". W Current Aspects of Blood Coagulation, Fibrinolysis, and Platelets, 29–34. Tokyo: Springer Japan, 1993. http://dx.doi.org/10.1007/978-4-431-68323-0_5.
Pełny tekst źródłaStreszczenia konferencji na temat "Serine protease inhibitor"
Tans, G., T. Janssen-Claessen, J. Rosing i J. H. Griffin. "APPLICATION OF SPECIFIC SERINE PROTEASE INHIBITORS IN ASSAYS FOR ACTIVATED CONTACT FACTORS." W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643301.
Pełny tekst źródłaCheung, A., i K. F. Hebert. "A TUMOR SERINE PROTEASE INHIBITOR WHICH MAY FUNCTION AS A TISSUE PLASMINOGEN ACTIVATOR INHIBITOR". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644448.
Pełny tekst źródłaStrandberg, L., D. Lawrence i T. Ny. "ISOLATION OF THE GENOMIC REGION CODING FOR TYPE-1 PLASMINOGEN ACTIVATOR INHIBITOR". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644439.
Pełny tekst źródłaCarrell, R. W., P. D. Christey i D. R. Boswell. "SERPINS: ANTITHROMBIN AND OTHER INHIBITORS OF COAGULATION AND FIBRINOLYSIS. EVIDENCE FROM AMINO ACID SEQUENCES". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1642896.
Pełny tekst źródłade Agostini, A., F. Barja, S. Carrel, P. C. Harpel i M. Schapira. "C1 -INHIBITOR: STRUCTURE-ACTIVITY RELATIONSHIPS". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1642903.
Pełny tekst źródłaBaker, J. B., M. P. McGrogan, C. Simonsen, R. L. Gronke i B. W. Festoff. "STRUCTURE AND PROPERTIES OF PROTEASE NEXIN I". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644765.
Pełny tekst źródłaSuzuki, Koji, Yoshihiro Deyashiki, Junji Nishioka, Kazunori Toma i Shuji Yamamoto. "THE INHIBITOR OF ACTIVATED PROTEIN C: STRUCTURE AND FUNCTION". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1642963.
Pełny tekst źródłaBergin, David A., Emer P. Reeves i Noel G. McElvaney. "Alpha-1 Antitrypsin: A Serine Protease Inhibitor With Novel Anti-TACE Activity". W American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a2639.
Pełny tekst źródłaCaruso, Joseph A., Cansu Karakas, Kelly Hunt i Khandan Keyomarsi. "Abstract 2466: Elafin, a serine protease inhibitor, is deregulated during breast cancer progression". W Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-2466.
Pełny tekst źródłaGu, Qijuan. "Identification, characterization and functional analysis of a serine protease inhibitor (CvT-serpin) from Cotesia vestalis teratocytes". W 2016 International Congress of Entomology. Entomological Society of America, 2016. http://dx.doi.org/10.1603/ice.2016.112554.
Pełny tekst źródłaRaporty organizacyjne na temat "Serine protease inhibitor"
Sanders, Tanya C. A New Class of Serine and Cysteine Protease Inhibitor with Chemotherapeutic Potential. Fort Belvoir, VA: Defense Technical Information Center, czerwiec 1999. http://dx.doi.org/10.21236/ada370850.
Pełny tekst źródłaSanders, Tanya C. A New Class of Serine and Cysteine Protease Inhibitor with Chemotherapeutic Potential. Fort Belvoir, VA: Defense Technical Information Center, lipiec 1998. http://dx.doi.org/10.21236/ada353868.
Pełny tekst źródłaLin, Chen-Yong. An Epithelial-Derived, Integral Membrane, Kunitz-Type Serine Protease Inhibitor in Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, sierpień 2005. http://dx.doi.org/10.21236/ada442974.
Pełny tekst źródłaLin, Chen-Yong. An Epithelial-Derived, Integral Membrane, Kunitz-Type Serine Protease Inhibitor in Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, sierpień 2002. http://dx.doi.org/10.21236/ada410178.
Pełny tekst źródłaLin, Chen-Yong. An Epithelial-Derived, Integral Membrane, Kunitz-Type serine Protease Inhibitor in Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, sierpień 2004. http://dx.doi.org/10.21236/ada435266.
Pełny tekst źródłaLin, Chen-Yong. An Epithelial-Derived Integral Membrane Kunitz-Type Serine Protease Inhibitor in Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, sierpień 2003. http://dx.doi.org/10.21236/ada420072.
Pełny tekst źródłaDickson, Robert B. A Novel Serine Protease Target for Prevention of Breast Cancer by a Soy Bean-Derived Inhibitor. Fort Belvoir, VA: Defense Technical Information Center, lipiec 2001. http://dx.doi.org/10.21236/ada396285.
Pełny tekst źródłaJohnson, Michael D. Breast Cancer Metastasis and the Balance of the Serine Protease Matriptase and Its Inhibitor KSPI-1. Fort Belvoir, VA: Defense Technical Information Center, lipiec 2001. http://dx.doi.org/10.21236/ada400456.
Pełny tekst źródłaDickson, Robert. A Novel Serine Protease Target for Prevention of Breast Cancer by a Soy Bean-Derived Inhibitor. Fort Belvoir, VA: Defense Technical Information Center, lipiec 2000. http://dx.doi.org/10.21236/ada383190.
Pełny tekst źródłaManulis, Shulamit, Christine D. Smart, Isaac Barash, Guido Sessa i Harvey C. Hoch. Molecular Interactions of Clavibacter michiganensis subsp. michiganensis with Tomato. United States Department of Agriculture, styczeń 2011. http://dx.doi.org/10.32747/2011.7697113.bard.
Pełny tekst źródła